On February 27, 2026, during an appearance on the Joe Rogan Experience, HHS Secretary Robert F. Kennedy Jr. announced that many currently restricted peptides are expected to move back to Category 1 status. If formally updated by the U.S. Food and Drug Administration, this would allow licensed U.S. compounding pharmacies to legally prepare these peptides again with a valid prescription. For patients who value medically guided peptide therapy, this is meaningful news and new peptides may be available soon.
How We Got Here
Between late 2023 and 2024, the FDA reclassified 19 commonly compounded peptides from Category 1 (eligible for compounding) to Category 2 (flagged for potential safety concerns).
Category 2 placement effectively stopped compounding pharmacies from preparing them, even for patients who had been using these therapies responsibly under physician supervision.
The agency cited concerns about limited human safety data and immunogenicity. However, a legal challenge argued that the required safety threshold to justify the restriction had not been met.
According to RFK Jr.’s recent statement, that review process is now reversing course for most of those peptides.
What Category 1 Actually Means
If these peptides return to Category 1:
Licensed 503A and 503B compounding pharmacies may legally prepare them
A prescription from a licensed clinician is still required
Pharmacies must comply with USP 795/797 quality standards
Products must come from regulated pharmaceutical suppliers
This does not mean the peptides are FDA-approved drugs. Full FDA approval requires large clinical trials demonstrating safety and efficacy for specific medical indications. Category 1 status simply restores legal compounding access under medical supervision.
Why This Matters for Patients
When the 19 peptides were restricted, demand did not disappear.
Instead, many individuals turned to:
Overseas suppliers
“Research use only” vendors
Online gray-market platforms
Those products often lack sterility testing, purity verification, and proper dosing controls. Contamination and mislabeling risks are real.
As RFK Jr. acknowledged publicly, restricting regulated access may have unintentionally pushed patients toward unregulated alternatives.
If compounding eligibility is restored, patients can return to physician-supervised, pharmaceutical-grade channels — which is always the safer path.
Peptides Likely to Return
What This Means at Flow Wellness
At Flow Wellness, we have always approached peptide therapy through a medical lens:
Comprehensive consultation
Baseline labs when appropriate
Individualized treatment plans
Ongoing monitoring
Pharmaceutical-grade sourcing
We do not support gray-market purchasing or unsupervised peptide use.
If these peptides officially return to Category 1 status, licensed compounding pharmacies may resume legal preparation under prescription. If they do not, we will continue to adapt responsibly within regulatory guidelines.
Our commitment does not change with headlines.
We prioritize safety, compliance, and thoughtful clinical decision-making — not shortcuts.
What You Should Do Now
There is no need to rush or stockpile.
Until the FDA formally updates its guidance:
Avoid purchasing peptides from unregulated sources
Continue working with licensed medical providers
Wait for confirmed regulatory publication
When changes become official, we will communicate clearly with our patients and discuss whether peptide therapy is appropriate for your goals.
Looking Ahead
Peptide medicine continues to evolve. Regulation is part of that evolution.
If several of the above peptides return to legal compounding status, this represents a shift back toward structured, physician-guided access rather than gray-market alternatives.
For patients focused on metabolic health, recovery, immune balance, and performance optimization, clarity and medical oversight matter more than ever.
At Flow Wellness in Bend, Oregon and Seattle, Washington, we will continue guiding patients through these changes with transparency and evidence-informed care.
Healthcare evolves. Innovation continues. And when new peptides become available soon, they should be introduced responsibly — with medical supervision at the center.
Updated June 2026
Author: Dr. Kevin Jones, MD
Medical Director
Flow Wellness
Frequently Asked Questions About New Peptides Becoming Available
What new peptides may become available in 2026?
Several peptides are being reviewed by the FDA and other regulatory agencies in 2026, including BPC-157, TB-500, KPV, MOTS-c, Semax, Epitalon, and DSIP. While availability and regulations can change, Flow Wellness closely monitors peptide developments so patients can stay informed about emerging treatment options.
Is BPC-157 becoming available again?
BPC-157 is one of the peptides currently receiving significant attention due to ongoing regulatory discussions. While no guarantees can be made regarding future availability, Flow Wellness follows FDA updates and peptide regulations closely and will share information as it becomes available.
What is TB-500 used for?
TB-500 is a peptide often discussed for its potential role in supporting recovery, mobility, and tissue healing. Research remains ongoing, and Flow Wellness recommends that patients only obtain peptides through licensed healthcare providers and licensed compounding pharmacies.
What is KPV peptide therapy?
KPV is a small peptide fragment being studied for its potential effects on inflammation and gastrointestinal health. Interest in KPV has increased due to its potential applications in wellness and recovery programs. Flow Wellness provides education on emerging peptide therapies as scientific evidence develops.
What is MOTS-c and why is it gaining popularity?
MOTS-c is a mitochondrial-derived peptide being studied for its potential role in metabolism, energy production, healthy aging, and body composition. Many longevity-focused providers are watching ongoing research, and Flow Wellness continues to monitor developments surrounding MOTS-c peptide therapy.
What are the potential benefits of Semax?
Semax is a peptide that has been researched for cognitive support, focus, mental performance, and neurological health. While it is not FDA-approved for these uses, interest in Semax continues to grow within the longevity and wellness communities. Flow Wellness provides educational resources on emerging cognitive-support peptides.
What is Epitalon peptide therapy?
Epitalon is a peptide commonly associated with healthy aging, sleep support, and longevity research. Although additional studies are needed, Flow Wellness frequently receives questions from patients interested in emerging longevity therapies such as Epitalon.
Are peptides FDA approved?
Many peptides used in wellness and longevity medicine are not FDA-approved for these specific indications. Some peptides may be legally prescribed through licensed healthcare providers and compounded by licensed pharmacies. Flow Wellness emphasizes transparency regarding peptide regulations and current evidence.
How can I obtain peptides safely?
The safest way to obtain peptides is through a licensed medical provider and a licensed U.S. pharmacy. Flow Wellness recommends avoiding peptides sold as “research chemicals” or products from unverified online sources due to quality and safety concerns.
When will the FDA make a decision about these peptides?
The FDA and advisory committees periodically review scientific evidence and regulatory considerations for peptides. Timelines can change, and final decisions are not guaranteed. Flow Wellness monitors regulatory updates and shares important developments with patients as new information becomes available.
Are peptides the same as steroids?
No. Peptides are short chains of amino acids that act as signaling molecules within the body, while anabolic steroids are hormone-based compounds derived from testosterone. Flow Wellness educates patients on the important differences between peptide therapy and steroid use.
Who may benefit from peptide therapy?
Depending on the specific peptide and individual health goals, peptide therapy may be considered for recovery, body composition, healthy aging, cognitive support, metabolic health, immune function, or overall wellness. Flow Wellness providers evaluate each patient individually to determine whether peptide therapy may be appropriate.
Does Flow Wellness offer peptide consultations?
Yes. Flow Wellness offers peptide consultations for patients interested in learning more about available peptide therapies, current regulations, safety considerations, and individualized wellness programs. Our providers can discuss which therapies may align with your health goals and current medical evidence.
Where can I learn more about peptide therapy?
Patients can explore Flow Wellness educational resources, schedule a peptide consultation, or contact our team directly to discuss current peptide availability, emerging therapies, and personalized wellness options. Flow Wellness is committed to helping patients navigate the rapidly evolving field of peptide medicine.
Related Peptide Resources
What Are Peptides? A Simple Guide You Can Understand
This Is Your Simple Guide To Learning About Peptides At Flow Wellness, we explain peptides in a way that makes sense in real life. They’re
Growth Hormone Peptides Explained
Growth Hormone Analogs: What They Are, How They Work, and Which One Is Right for You A medical guide from Flow Wellness Growth hormone (GH)
The Peptide to Choose for Gentle Recovery, Energy, and Healthy Aging
A Natural, Gentle Way to Support Recovery, Metabolism & Healthy Aging Peptide therapy has quickly become one of the most talked-about tools in modern wellness—and
